BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23226197)

  • 21. Case report: Kaposi's sarcoma: an unusual presentation.
    Young AC; Mazzullo JM; Simon AR; Skolnik PR
    MedGenMed; 2001 Sep; 3(4):8. PubMed ID: 11698915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.
    Dittmer DP
    mBio; 2011; 2(6):e00138-11. PubMed ID: 22045987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV/AIDS-associated Kaposi's sarcoma with multiple skin-mucosal disseminations following ultraviolet (puva) photochemotherapy.
    Popivanova NI; Chudomirova KN; Baltadzhiev IG; Abadjieva TI
    Folia Med (Plovdiv); 2010; 52(3):56-61. PubMed ID: 21053674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical presentation and natural history of AIDS--related Kaposi's sarcoma.
    Dezube BJ
    Hematol Oncol Clin North Am; 1996 Oct; 10(5):1023-9. PubMed ID: 8880194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions.
    Pak F; Mwakigonja AR; Kokhaei P; Hosseinzadeh N; Pyakurel P; Kaaya E; Bogdanovic G; Selivanova G; Biberfeld P
    Eur J Cancer; 2007 Aug; 43(12):1877-82. PubMed ID: 17627810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
    AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy.
    Mönkemüller KE; Lazenby AJ; Lee DH; Loudon R; Wilcox CM
    Dig Dis Sci; 2005 Feb; 50(2):230-4. PubMed ID: 15745077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Upper gastrointestinal endoscopy during Kaposi's sarcoma to the Point G Hospital, Bamako (Mali): case study 20].
    Soukho-Kaya A; Minta DK; Diarra MT; Konate A; Diallo B; Sidibe AT; Dembele M; De O; Doumbia AA; Dao K; Tolo N; Camara BD; Sy D; Traore CB; Maiga MY; Traore HA
    Mali Med; 2012; 27(1):62-5. PubMed ID: 22766108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
    J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
    Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
    AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
    Mani D; Neil N; Israel R; Aboulafia DM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(5):279-85. PubMed ID: 19721098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.
    Tamanaha-Nakasone A; Uehara K; Tanabe Y; Ishikawa H; Yamakawa N; Toyoda Z; Kurima K; Kina S; Tsuneki M; Okubo Y; Yamaguchi S; Utsumi D; Takahashi K; Arakawa H; Arasaki A; Kinjo T
    Sci Rep; 2019 Apr; 9(1):6416. PubMed ID: 31015491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
    Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.
    Reed JA; Nador RG; Spaulding D; Tani Y; Cesarman E; Knowles DM
    Blood; 1998 May; 91(10):3825-32. PubMed ID: 9573020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of Kaposi's sarcoma: experience from a Taiwanese medical center.
    Huang AY; Lin CL; Chen GS; Hu SC
    Int J Dermatol; 2019 Dec; 58(12):1388-1397. PubMed ID: 31102268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification.
    Laine L; Amerian J; Rarick M; Harb M; Gill PS
    Am J Gastroenterol; 1990 Aug; 85(8):959-61. PubMed ID: 1695812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False-Negative Results of Endoscopic Biopsy in the Diagnosis of Gastrointestinal Kaposi's Sarcoma in HIV-Infected Patients.
    Nagata N; Sekine K; Igari T; Hamada Y; Yazaki H; Ohmagari N; Akiyama J; Shimbo T; Teruya K; Oka S; Uemura N
    Patholog Res Int; 2012; 2012():854146. PubMed ID: 23227427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to: a retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
    Maurer T; Leslie K; Unemori P
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):73. PubMed ID: 20484734
    [No Abstract]   [Full Text] [Related]  

  • 39. Kaposi's sarcoma: a reevaluation.
    Orfanos CE; Husak R; Wölfer U; Garbe C
    Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
    Wilkinson J; Cope A; Gill J; Bourboulia D; Hayes P; Imami N; Kubo T; Marcelin A; Calvez V; Weiss R; Gazzard B; Boshoff C; Gotch F
    J Virol; 2002 Mar; 76(6):2634-40. PubMed ID: 11861829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.